The Effect of Inadvertent Perioperative Hypothermia on Surgical Site Infection in Laparoscopic Choleistectomy.

Sponsor
Cumhuriyet University (Other)
Overall Status
Recruiting
CT.gov ID
NCT06035627
Collaborator
(none)
100
2
15
50
3.3

Study Details

Study Description

Brief Summary

There are conflicting results in the literature explaining the relationship between surgical site infection (SSI) and inadvertent perioperative hypothermia (IPH). Although it is thought that the risk of IPH is lower in laparoscopic surgery types due to the short duration of the surgical procedure, these conflicting results raise doubts as to whether there is a relationship between IPH and SSI in laparoscopic surgery patients. A randomized controlled study will be planned in the future to examine the effect of IPH on SSI in patients who will undergo laparoscopic cholecystectomies. The study will be conducted in the general surgery clinic and operating room of a university hospital. It will be completed with a total of 100 patients, 50 of whom will be in the case group, and 50 will be in the control group.

Condition or Disease Intervention/Treatment Phase
  • Other: Prevention hypothermia

Detailed Description

Objective: This study was conducted to examine the effect of inadvertent perioperative hypothermia (IPH) on Surgical Site Infection (SSI) in patients undergoing laparoscopic cholecystectomy.

Summary of Background Data: There are conflicting results in the literature explaining the relationship between SSI and IPH. Although the risk of IPH is thought to be lower in laparoscopic surgery types due to the short duration of the surgical procedure, these conflicting results raise doubts about the existence of a relationship between IPH and SSI in laparoscopic surgery patients.

Methods: This study will be a quasi-experimental and randomized controlled study in the future. The study will be conducted with patients who will have undergone laparoscopic cholecystectomy in the general surgery clinic and operating room of a university hospital. The study will be completed with a total of 100 patients, 50 in the case group, and 50 in the control group. During the study, preoperative, intraoperative, and postoperative body temperatures, as well as biomarkers of the patients, will be monitored using a form developed by the researchers. Additionally, patients will be followed up postoperatively to evaluate the potential impact of IPH on SSI.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
100 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Uncontrolled Inadvertent Perioperative Hypothermia as a Risk Factor for Surgical Site Infection in Patients Undergoing Laparoscopic Cholecystectomy: A Randomized Controlled Trial
Actual Study Start Date :
May 15, 2023
Anticipated Primary Completion Date :
May 15, 2024
Anticipated Study Completion Date :
Aug 15, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental group

The population of the study consisted of patients who were being treated in the general surgery clinic of the hospital, who met the sampling criteria, who were to undergo laparoscopic cholecystectomy, and who agreed to participate in the study. The sample size of the study was determined by the G*Power 3.1.9.7 program. In the power analysis, when α =0.05, β=0.10, and 1-β =0.90, the sample size was determined as 50 people per group and a total of 100 people.

Other: Prevention hypothermia
Hypothermia was prevented by warming the case group. control group remained stable. As a result, the presence of surgical site infection was followed.

Control group

The population of the study consisted of patients who were being treated in the general surgery clinic of the hospital, who met the sampling criteria, who were to undergo laparoscopic cholecystectomy, and who agreed to participate in the study. The sample size of the study was determined by the G*Power 3.1.9.7 program. In the power analysis, when α =0.05, β=0.10, and 1-β =0.90, the sample size was determined as 50 people per group and a total of 100 people.

Outcome Measures

Primary Outcome Measures

  1. Prevention of inadvertent perioperative hypothermia [September 15, 2022- September 15, 2023]

    This study aims to evaluate whether inadvertent perioperative hypothermia has an effect on surgical site infection. For this, applications to prevent hypothermia will be applied to the patients in the experimental group

Secondary Outcome Measures

  1. Following surgical site infection [16 September 16, 2023 - October 25, 2023]

    After the applications for preventing hypothermia in the experimental group and the patients in the experimental and control groups will be examined for surgical site infection.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Being aged 18-65 years old,

  • Having an ASA score of I-II,

  • Remaining in the hospital for at least 24 hours in the postoperative period,

  • Undergoing laparoscopic cholecystectomy

Exclusion Criteria:
  • Being under 18 or over 65,

  • Having an ASA score above III,

  • Requiring emergency surgery

  • Having a neurological, psychiatric, or neuromuscular disease,

  • Being addicted to alcohol and/or other toxic substances,

  • Being pregnant or having a suspected pregnancy,

  • Undergoing open surgery, or being converted to an open procedure during surgery,

  • Having symptoms of fever

  • Having an active infection excluding cholecystitis.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cumhuriyet University Sivas Suşehri Turkey 58140
2 Sivas Cumhuriyet University Sivas Turkey 58140

Sponsors and Collaborators

  • Cumhuriyet University

Investigators

  • Principal Investigator: Pınar YILMAZ EKER, Ph.D, corresponding researcher

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Pınar YILMAZ EKER, Asst. Prof, Cumhuriyet University
ClinicalTrials.gov Identifier:
NCT06035627
Other Study ID Numbers:
  • PYILMAZEKER
First Posted:
Sep 13, 2023
Last Update Posted:
Sep 13, 2023
Last Verified:
Sep 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Pınar YILMAZ EKER, Asst. Prof, Cumhuriyet University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 13, 2023